Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers B > Headlines for BioCryst Pharmaceuticals, Inc. > News item |
BioCryst Pharmaceuticals files $70 million shelf
By Devika Patel
Knoxville, Tenn., Dec. 1 - BioCryst Pharmaceuticals, Inc. filed a $70 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock, depositary shares, stock purchase contracts, warrants and units.
The securities may be structured as convertibles.
Proceeds will be used for general corporate purposes.
BioCryst is a Birmingham, Ala., pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.